Waran Seri I Kokoh Exa Nusantara Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Waran Seri I Kokoh Exa Nusantara Tbk. trades at Rp6 (market cap 2.79B, 517.1K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is far larger — about 59× Waran Seri I Kokoh Exa Nusantara Tbk.'s market cap, and Waran Seri I Kokoh Exa Nusantara Tbk. is more actively traded (517.1K versus 62.5K). Which is the better fit depends on your goals.
| KOCI-W | OBAT | |
|---|---|---|
Market Cap | 2.79B | 164.65B |
Volume | 517.1K | 62.5K |
Lot | 5.17K | 625 |
Turnover | 3.2M | 15.03M |
Average Price | 6.2 | 240.55 |
Value | 3.2M | 15.03M |
Indicative Equilibrium Price | 6 | 238 |
Indicative Equilibrium Volume | 1.11K | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Kokoh Exa Nusantara Tbk (the Entity) was established based on Notarial Deed No. 173, dated July 31, 2019 of Dwi Rossulliati, S.H., notary in Mojokerto Regency. The Entity started its commercial operations in 2020. PT Exa Nusa Persada is its ultimate parent entity.
Read more on KOCI-W →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →